Novel Treatment Options for CKD in Type 2 Diabetes – Evaluating Latest Landmark Trial Results episode artwork

EPISODE · Aug 3, 2022 · 20 MIN

Novel Treatment Options for CKD in Type 2 Diabetes – Evaluating Latest Landmark Trial Results

from Keeping Current CME

Can you tell nonsteroidal from steroidal mineralocorticoid receptor antagonists? Credit available for this activity expires: 08/02/23 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/977193?src=mkm_podcast_addon_977193  

Episode metadata supplied by the publisher feed · Published Aug 3, 2022

Embed this episode

NOW PLAYING

Novel Treatment Options for CKD in Type 2 Diabetes – Evaluating Latest Landmark Trial Results

0:00 20:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 20 minutes long.

When was this Keeping Current CME episode published?

This episode was published on August 3, 2022.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!